Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University462 Ruijin Hospital282 Shanghai Zhongshan Hospital169 RenJi Hospital133 Children's Hospital of Fudan University84
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Shanghai

3879 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Tongji University
Observational
1,000
Shanghai
2025-07-15
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
13
Shanghai
2025-07-15
Active, closed
Aligos Therapeutics
Phase 2
200
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Nanjing, Shanghai
2025-07-15
Not yet open
ChinaNorm
Not applicable
60
Shanghai
2025-07-15
Recruiting
Hutchmed
Phase 1
52
Shanghai
2025-07-15
Not yet open
Yun Qian
Not applicable
318
Jinjiang, Yancheng, Shanghai
2025-07-15
Recruiting
Shanghai Zhongshan Hospital
Phase 1
60
Shanghai
2025-07-15
Recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4
64
Shanghai
2025-07-14
Recruiting
Study of GV20-0251 in Participants With Solid Tumor Malignancies
NCT07070518Solid Tumor Cancer, Adult Refractory Cancer, Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma
DrugGV20-0251
GV20 Therapeutics
Phase 1/2
350
Beijing, Shanghai
2025-07-11
Recruiting
Bristol-Myers Squibb
Phase 3
426
Beijing, Haidian District, Chongqing, Guangzhou, Shenzhen, Changsha, Nanjing, Shanghai
2025-07-10
Not yet open
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase 1
36
Shanghai
2025-07-10
Recruiting
A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes
NCT07060378Lung Lesions, Mediastinal and Hilar Lymph Node Enlargement
Shanghai Chest Hospital
Not applicable
250
Shanghai
2025-07-10
Recruiting
A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies
NCT07070323T-Cell Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia, T-cell Malignancies
Beijing GoBroad Hospital
Phase 1/2
54
Beijing, Shanghai, Chengdu
2025-07-09
Recruiting
Evopoint Biosciences Inc.
Phase 3
226
Shanghai, Beijing, Binzhou, Changsha, Changzhou, Chengdu, Chongqing, Fuyang
2025-07-08
Recruiting
Fudan University
Phase 3
2,306
Shanghai
2025-07-08
Recruiting
Akeso
Phase 3
536
Shanghai
2025-07-08
Active, closed
Sanofi
Phase 2
105
Huizhou, Guangzhou, Nanjing, Suzhou, Wuxi, Shanghai, Hangzhou, Ningbo
2025-07-07
Recruiting
Perceptual Evaluation and Rehabilitation System Development for Congenital Hearing Loss
NCT07024524Congenital Hearing Loss, Gene Therapy, Speech Perception, Rehabilitation
Eye & ENT Hospital of Fudan University
Not applicable
210
Shanghai
2025-07-04
Recruiting
Shenzhen Ionova Life Sciences Co., Ltd.
Phase 1/2
201
Shanghai
2025-07-04
Recruiting
HC Biopharma Inc.
Phase 1
252
Shanghai
2025-07-04
By invitation
Shanghai Punan Hospital of Pudong New District
Not applicable
22
Shanghai
2025-07-03
Recruiting
Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder
NCT07198594Obsessive Compulsive Disorder (OCD), Obsessive - Compulsive Disorder
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Not applicable
20
Shanghai
2025-07-03
Recruiting
Shanghai Chest Hospital
Not applicable
186
Jinan, Shanghai, Hangzhou
2025-07-02
Recruiting
Fudan University
Phase 2
146
Shanghai
2025-07-02
Recruiting
Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
NCT07053358Neovascular Age-related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
10
Shanghai
2025-07-02
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1
630
Beijing, Guangzhou, Harbin, Nanchang, Shenyang, Jinan, Shanghai, Tianjin
2025-07-02
Not yet open
Shanghai Chest Hospital
Phase 2
40
Shanghai
2025-07-01
Not yet open
Intervention Study on Digital Health Management
NCT06949306Hypertension, Hyperlipidemia
Shanghai 10th People's Hospital
Not applicable
300
Shanghai
2025-07-01
Not yet open
Shanghai Chest Hospital
Not applicable
150
Shanghai
2025-07-01
Not yet open
RenJi Hospital
Phase 3
436
Shanghai
2025-07-01
Recruiting
Shanghai Zhongshan Hospital
Phase 3
144
Shanghai
2025-07-01
Not yet open
Shanghai Changzheng Hospital
Not applicable
330
Shanghai
2025-07-01
Recruiting
AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases
NCT07087418Digestive Diseases, Radiology, AI (Artificial Intelligence), Imaging
First Affiliated Hospital, Sun Yat-Sen University
Observational
5,000
Shanghai
2025-07-01
Not yet open
Fudan University
Phase 2
35
Shanghai
2025-07-01
Not yet open
Ruijin Hospital
Not applicable
38
Shanghai
2025-07-01
Recruiting
EGR2 and NLRP3 Pathways in Obstructive Sleep Apnea-Related Cognitive and Mood Disorders
NCT07120711Obstructive Sleep Apnea-Hypopnea Syndrome, Anxiety Disorders, Depressive Disorders
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2025-07-01
Not yet open
Fudan University
Phase 2
20
Shanghai
2025-07-01
Active, closed
EndoVascular Aortic Dissection Early vs Delayed
NCT07143071Aortic Dissection Type B
Shanghai Zhongshan Hospital
Observational
4,068
Shanghai
2025-07-01
Recruiting
Shanghai Tongji Hospital, Tongji University School of Medicine
Not applicable
380
Shanghai
2025-07-01
Not yet open
DCB for CAD With Type 2 Diabetes
NCT07009938Coronary Artery Disease, Diabete Type 2
Shanghai 10th People's Hospital
Not applicable
1,000
Kaifeng, Luoyang, Zhengzhou, Shanghai, Yibin, Ningbo
2025-07-01
Not yet open
Shanghai Children's Medical Center
Not applicable
200
Shanghai
2025-07-01
Recruiting
Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
NCT06311955Thymic Epithelial Tumor, Radiotherapy Side Effect, Carbon Ion Radiotheray, Heavy Ion Radiotherapy
Jian Chen
Phase 2
48
Shanghai
2025-07-01
Recruiting
Shanghai Zhongshan Hospital
Observational
900
Shanghai
2025-07-01
Not yet open
RenJi Hospital
Observational
40
Shanghai
2025-07-01
Active, closed
Changhai Hospital
Not applicable
200
Shanghai
2025-07-01
Not yet open
Ruijin Hospital
Not applicable
46
Shanghai
2025-07-01
Recruiting
Shanghai Municipal Hospital of Traditional Chinese Medicine
Not applicable
86
Shanghai
2025-07-01
Not yet open
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
NCT07035821Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients, Pediatric Cancer
DrugOlanzapine
Shanghai Children's Medical Center
Phase 3
100
Shanghai
2025-07-01
Active, closed
OCT in Endovascular Recanalization of Chronic Carotid Artery Occlusion
NCT07740408Chronic Internal Carotid Artery Occlusion, Carotid Artery Occlusion
RenJi Hospital
Observational
60
Shanghai
2025-07-01
By invitation
Junbo Ge
Not applicable
40
Hefei, Suzhou, Shanghai
2025-07-01
Recruiting
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
NCT07047339Colitis, IBD (Inflammatory Bowel Disease), Probiotic Intervention
Changhai Hospital
Phase 2/3
120
Shanghai
2025-07-01
Not yet open
Changhai Hospital
Not applicable
270
Shanghai
2025-07-01
Recruiting
Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment
NCT07067385Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant Therapy, Gastrointestinal Tumors
Ruijin Hospital
Phase 1
40
Shanghai
2025-07-01
Recruiting
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Phase 1
40
Hangzhou, Shanghai
2025-07-01
Recruiting
Ruijin Hospital
Phase 2
45
Shanghai
2025-07-01
Not yet open
REST4-AAA Registry
NCT07056491Abdominal Aortic Aneurysm
RenJi Hospital
Observational
70
Shanghai
2025-07-01
Recruiting
Children's Cancer Group, China
Phase 2/3
87
Shanghai
2025-07-01
Recruiting
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
NCT07043166Metabolic Syndrome, Diabetes, Obesity and Overweight, Hypertension
Shanghai Changzheng Hospital
Observational
4,094
Shanghai
2025-07-01
Not yet open
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1
180
Wenzhou, Shanghai
2025-07
Not yet open
Surgery for Relapsed Ovarian Cancer in Precision
NCT06602063Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
DrugLenvatinib
Shanghai Gynecologic Oncology Group
Phase 1/2
33
Shanghai, Wuhan
2025-07
Not yet open
Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07079410Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma, Resectable Oral and Oropharyngeal Squamous Cell Carcinoma
DrugsCetuximab·Sintilimab
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2025-07
Not yet open
Zhigang Li
Phase 2
164
Shanghai
2025-07
Not yet open
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
212
Shanghai
2025-07
Not yet open
Fudan University
Phase 2
48
Shanghai
2025-06-30
Recruiting
Early Feasibility Study of Surgical Implantation of a Polymer Prosthetic Mitral and Aortic Valve
NCT07097740AORTIC VALVE DISEASES, Mitral Valve Disease, Aortic Stenosis, Aortic Regurgitation
Mitrassist Lifesciences Limited Co., Ltd.
Not applicable
10
Shanghai
2025-06-27
Recruiting
Evidence-based Practice in the Management of Gastric Tube Placement in Children
NCT07038538Hospitalized Children, Nursing, Enteral Nutrition Therapy
Children's Hospital of Fudan University
Not applicable
2,750
Shanghai, Beijing, Chongqing, Gansu, Guangdong, Hefei, Henan, Hunan
2025-06-26
Not yet open
Changhai Hospital
Not applicable
148
Shanghai
2025-06-25
Not yet open
Changhai Hospital
Not applicable
270
Shanghai
2025-06-25
Active, closed
Incyte Corporation
Phase 1/2
32
Beijing, Chengdu, Chongoing, Guangzhou, Hangzhou, Shanghai, Tianjin, Wuhan
2025-06-25
Not yet open
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
NCT07036185Gastric/Gastroesophageal Junction Cancer, Breast Cancer, Colorectal Cancer, Non-small Cell Lung Cancer (NSCLC)
Shanghai Bao Pharmaceuticals Co., Ltd.
Phase 1
66
Shanghai
2025-06-24
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
74
Shanghai
2025-06-24
Active, closed
Shanghai Minhang Central Hospital
Observational
160
Shanghai
2025-06-23
Recruiting
Shanghai Zhongshan Hospital
Phase 2
60
Shanghai
2025-06-23
By invitation
Shanghai East Hospital
Not applicable
46
Shanghai
2025-06-21
Recruiting
SSGJ-707 in Advanced Non-Small Cell Lung Cancer
NCT06980272Advanced Non-Small Cell Lung Cancer
DrugsPF-08634404·Pembrolizumab
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 3
420
Shanghai
2025-06-20
Recruiting
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
NCT07028086Acute Myeloid Leukemia, Myeloid Sarcoma
Ruijin Hospital
Phase 2
48
Shanghai
2025-06-20
Recruiting
A Study in Children With Achondroplasia
NCT07301463Achondroplasia
Abbisko Therapeutics Co, Ltd
Observational
260
Beijing, Guangzhou, Zhengzhou, Wuhan, Shanghai, Chengdu, Hangzhou
2025-06-20
Not yet open
Effect of In-Place Slow Jogging on Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06994234Metabolic Dysfunction-Associated Steatotic Liver Disease
Shanghai East Hospital
Not applicable
82
Shanghai
2025-06-20
Not yet open
MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.
NCT07000292Lupus Nephritis (LN), ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital
Phase 1/2
12
Shanghai
2025-06-20
Recruiting
Shanghai Zhongshan Hospital
Phase 2
38
Shanghai
2025-06-20
Recruiting
Children's Hospital of Fudan University
Not applicable
394
Shanghai
2025-06-20
Recruiting
Shanghai East Hospital
Phase 3
978
Shanghai
2025-06-19
Recruiting
Ruijin Hospital
Phase 1
10
Qionghai, Shanghai
2025-06-19
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
25
Shanghai
2025-06-19
Recruiting
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Phase 1
36
Nanjing, Beijing, Shanghai
2025-06-18
Active, closed
Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
NCT07193615Alpha-1 Antitrypsin Deficiency (AATD)
RenJi Hospital
Early Phase 1
18
Shanghai
2025-06-18
Recruiting
Ruijin Hospital
Phase 1
10
Qionghai, Shanghai
2025-06-18
Recruiting
Huashan Hospital
Phase 2
80
Beijing, Chengdu, Shanghai
2025-06-18
Recruiting
Ruijin Hospital
Observational
120
Shanghai
2025-06-17
Recruiting
Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns
NCT07025408Burn, Burn Wounds - Partial Thickness (2nd Degree)
Shanghai Bao Pharmaceuticals Co., Ltd.
Phase 2
144
Shanghai
2025-06-16
Recruiting
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
60
Shanghai
2025-06-16
Recruiting
Fudan University
Phase 3
1,903
Shanghai
2025-06-15
Recruiting
Shanghai Minimally Invasive Surgery Center
Observational
250
Shanghai
2025-06-15
Recruiting
Shanghai Minimally Invasive Surgery Center
Observational
250
Shanghai
2025-06-15
Active, closed
Eastern Hepatobiliary Surgery Hospital
Phase 2
59
Shanghai
2025-06-14
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
18
Shanghai
2025-06-14
Recruiting
Study of Ravulizumab in Pediatric Participants With Primary IgAN
NCT07024563IgAN, IgAVN, Immunoglobulin A Nephropathy, Immunoglobulin A Vasculitis Associated Nephritis
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
36
Beijing, Shanghai
2025-06-14
Recruiting
Beijing StoneWise Technology Co., Ltd
Phase 1
60
Shanghai
2025-06-13
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
316
Shanghai
2025-06-13
Recruiting
Shanghai East Hospital
Observational
527
Shanghai
2025-06-12
Recruiting
A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
NCT07376707CRC (Colorectal Cancer), Melanoma (Skin Cancer), HCC - Hepatocellular Carcinoma, NSCLC (Non-small Cell Lung Cancer)
DrugNivolumab
Hefei TG ImmunoPharma Co., Ltd.
Phase 1
194
Shanghai
2025-06-12
Not yet open
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1/2
65
Shanghai
2025-06-12
Recruiting
Akeso
Phase 3
999
Harbin, Shanghai, Hangzhou
2025-06-11
Recruiting
Fudan University
Observational
60
Shanghai
2025-06-11
By invitation
tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients.
NCT07074704Negative Symptoms in Schizophrenia, Cognition Function
Tongji University
Not applicable
60
Shanghai
2025-06-11
Recruiting
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
NCT07050394Colorectal Cancer Metastatic, Colorectal Cancer Recurrent, Colorectal Cancer Stage IV
Shanghai Changzheng Hospital
Early Phase 1
20
Shanghai
2025-06-10
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
46
Shanghai
2025-06-10
Recruiting
Ruijin Hospital
Phase 2/3
126
Shanghai
2025-06-10
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
82
Shanghai
2025-06-10
Recruiting
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
NCT06993844Advanced Solid Tumors, Advanced Breast Cancer
DrugFulvestrant
Ensem Therapeutics
Phase 1/2
233
Beijing, Fuzhou, Guangzhou, Shandong, Shanghai
2025-06-10
Active, closed
Merck Sharp & Dohme LLC
Phase 2
149
Guangzhou, Changsha, Changchun, Shanghai, Ürümqi, Hangzhou
2025-06-09
Recruiting
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 1
55
Shanghai
2025-06-09
Recruiting
Ruijin Hospital
Phase 2
30
Shanghai
2025-06-08
Not yet open
Yilai Shu
Not applicable
60
Shanghai
2025-06-07
Active, closed
A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases
NCT06786338IgA Nephropathy (IgAN), C3 Glomerulopathy, IC-MPGN
DrugSGB-9768
Suzhou Sanegene Bio Inc.
Phase 2
45
Beijing, Changsha, Chengdu, Guiyang, Hangzhou, Shanghai, Yangzhou, Yinchuan
2025-06-06
Recruiting
Fudan University
Not applicable
142
Shanghai
2025-06-05
Recruiting
Boehringer Ingelheim
Phase 2
300
Chengdu, Shanghai, Shenyang, Shijiazhuang, Taiyuan
2025-06-05
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
84
Shanghai
2025-06-04
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 3
450
Shanghai
2025-06-04
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
1,450
Nanjing, Shanghai
2025-06-03
Active, closed
Shanghai Chest Hospital
Phase 2/3
97
Shanghai
2025-06-03
Recruiting
Sanofi
Phase 2
99
Changsha, Changzhou, Guangzhou, Hangzhou, Nanchang, Shanghai, Shenyang
2025-06-03
Recruiting
The Hong Kong Polytechnic University
Observational
173
Zhengzhou, Shanghai, Shenzhen
2025-06-02
Recruiting
Ruijin Hospital
Phase 1/2
55
Shanghai
2025-06-02
Not yet open
Fudan University
Phase 3
2,508
Shanghai
2025-06-02
By invitation
Fudan University
Observational
60
Shanghai
2025-06-01
Not yet open
Shanghai Mental Health Center
Not applicable
30
Shanghai
2025-06-01
By invitation
Comparison of MIPPED-C and Surgical Necrosectomy in Pancreatic Necrosis Outcomes
NCT07097753Acute Pancreatitis (AP), Acute Pancreatitis With Infected Necrosis
Ruijin Hospital
Observational
144
Shanghai
2025-06-01
Recruiting
Parent-Mediated Social Cognition Intervention for Young Children With Autism Spectrum Disorder
NCT07708246Autism, Intervention (Training) Condition, Social Cognition, Cognition Improvement
Children's Hospital of Fudan University
Not applicable
60
Shanghai
2025-06-01
Not yet open
Shanghai Tongji Hospital, Tongji University School of Medicine
Early Phase 1
24
Shanghai
2025-06-01
Not yet open
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
NCT06846424Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group
Phase 1
24
Shanghai
2025-06-01
Recruiting
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
NCT07002177Metastatic Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Locally Advanced Breast Cancer (LABC)
DrugsFWD1802·Everolimus·Ribociclib·Abemaciclib
Forward Pharmaceuticals Co., Ltd.
Phase 1/2
196
Shanghai
2025-06-01
Recruiting
Shanghai Children's Medical Center
Not applicable
60
Shanghai
2025-06-01
Not yet open
Fudan University
Not applicable
531
Shanghai
2025-06-01
Recruiting
Early-Onset Myopia Intervention Project
NCT07176949Myopia, Pre-myopia
DrugAtropine eye
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
508
Shanghai
2025-06-01
Recruiting
Adjuvant Pancreatic Therapy Guided by MRD
NCT06966440Pancreatic Adenocarcinoma Resectable
Ruijin Hospital
Not applicable
856
Shanghai
2025-06-01
Recruiting
CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
NCT07022964T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital
Phase 1/2
36
Beijing, Shanghai
2025-06-01
Not yet open
Shanghai Zhongshan Hospital
Phase 2
76
Shanghai
2025-06-01
Not yet open
Shanghai 10th People's Hospital
Not applicable
2,000
Shanghai
2025-06-01
Recruiting
Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer
NCT06942234Inoperable Locally Advanced HER2-Negative Breast Cancer, Metastatic HER2-Negative Breast Cancer
DrugsJSKN016·Eribulin·Capecitabine·Paclitaxel
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 1/2
180
Shanghai
2025-06-01
Not yet open
Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage
NCT06965556Breast Carcinoma, Patient Education, Perioperative Care, Psychological Intervention
Fudan University
Not applicable
1,138
Shanghai
2025-06-01
Recruiting
Children's Hospital of Fudan University
Phase 4
100
Shanghai
2025-06-01
Recruiting
Standardized Implementation and Quality Assessment System for Confocal Enteroscopy
NCT07363291Confocal Enteroscopy, Quality Assessment System, Standardized Implementation
Shanghai Jiao Tong University School of Medicine
Observational
600
Hefei, Ningbo, Kashgar, Shanghai
2025-06-01
Recruiting
Fudan University
Observational
300
Shanghai
2025-06-01
Not yet open
Fudan University
Not applicable
1,596
Shanghai
2025-06-01
Not yet open
RCT of Minimalist vs Standard Procedure for LAAC in NVAF Patients
NCT06969118Atrial Fibrillation, Left Atrial Appendage Occlusion, General Anesthesia, Local Anesthesia
Shanghai Zhongshan Hospital
Not applicable
200
Shanghai
2025-06-01
Recruiting
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
80
Shanghai
2025-06-01
Recruiting
Gao Xiaofeng
Not applicable
116
Shanghai
2025-06-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
5,000
Hangzhou, Shanghai
2025-06-01
Not yet open
Fudan University
Not applicable
338
Shanghai
2025-06-01
Not yet open
Sun Yuting
Observational
1,309
Shanghai
2025-06-01
Recruiting
Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC
NCT07003022Colo-rectal Cancer, MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
DrugsFruquintinib·Cadonilimab
Fudan University
Phase 2
40
Shanghai
2025-06-01
Recruiting
Shanghai Zhongshan Hospital
Early Phase 1
60
Shanghai
2025-06
Recruiting
Shanghai Zhongshan Hospital
Early Phase 1
30
Shanghai
2025-06
Not yet open
Shanghai East Hospital
Early Phase 1
40
Shanghai
2025-05-30
Recruiting
Shanghai Jiao Tong University School of Medicine
Early Phase 1
60
Shanghai
2025-05-30
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
DrugOctreotide LAR
Novartis Pharmaceuticals
Phase 3
240
Beijing, Shanghai
2025-05-30
Active, closed
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2
234
Shanghai
2025-05-30
Not yet open
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
762
Hangzhou, Shanghai
2025-05-30
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
72
Hefei, Beijing, Harbin, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai
2025-05-29
Recruiting
Hansoh BioMedical R&D Company
Phase 1
502
Shanghai
2025-05-29
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
72
Shanghai
2025-05-29
Recruiting
Takeda
Phase 2
192
Chongqing, Guangdong, Guangzhou, Shanghai
2025-05-28
Recruiting
Merck Sharp & Dohme LLC
Phase 2
144
Beijing, Chongqing, Fuzhou, Nanning, Zhengzhou, Nanjing, Shanghai
2025-05-28
Not yet open
Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients
NCT06978946Alzheimer Disease, Lewy Body Dementia (LBD), Frontotemporal Dementia (FTD), Dementia
RenJi Hospital
Not applicable
85
Shanghai
2025-05-28
Recruiting
Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC
NCT07705438Triple Negative Breast Cancer, Immune Checkpoint Inhibitor, Granzyme B PET/CT
Fudan University
Observational
30
Shanghai
2025-05-28
Recruiting
Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer
NCT06970353Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS Mutation, Advanced PDTC or ATC With NRAS Mutation
DrugsPembrolizumab/Finotonlimab·Tunlametinib
Fudan University
Phase 2
40
Shanghai
2025-05-27
Recruiting
GeneCradle Inc
Phase 3
50
Beijing, Shanghai, Shenzhen, Suzhou, Wuhan
2025-05-27
Recruiting
Ruijin Hospital
Phase 1
56
Shanghai
2025-05-26
Recruiting
Fudan University
Phase 1/2
68
Shanghai
2025-05-26
Recruiting
Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
NCT07003568Relapsed or Refractory Multiple Myeloma (RRMM)
Beijing GoBroad Hospital
Phase 1
18
Shanghai
2025-05-25
Recruiting
Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
NCT07003555Relapsed or Refractory Multiple Myeloma (RRMM)
Beijing GoBroad Hospital
Phase 1
18
Shanghai
2025-05-25
Recruiting
Jiannan Huang
Not applicable
80
Shanghai
2025-05-25
Recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
550
Shanghai
2025-05-25
Recruiting
Fudan University
Observational
100
Shanghai
2025-05-23
Recruiting
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
50
Shanghai
2025-05-23
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Hefei, Fuzhou, Guangzhou, Harbin, Zhenngzhou, Wuhan, Xining, Shanghai
2025-05-22
Active, closed
AstraZeneca
Phase 2
16
Jinan, Nanjing, Shanghai
2025-05-20
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
220
Beijing, Haerbin, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Chengdu
2025-05-20
Recruiting
A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
NCT07080021Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
Ruijin Hospital
Observational
119
Shanghai
2025-05-20
Recruiting
Shanghai Zhongshan Hospital
Phase 4
2,846
Shanghai
2025-05-19
Active, closed
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
180
Shanghai
2025-05-17
Recruiting
A Phase I Clinical Study of a Single Dose of KLA480
NCT07030790Healthy Participants
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Phase 1
20
Shanghai
2025-05-17
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Guangzhou, Shantou, Changsha, Changchun, Hangzhou, Beijing, Shanghai
2025-05-16
Recruiting
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
NCT07390838Liver Cancer (Locally Advanced or Metastatic), Lung Cancer (NSCLC), Head and Neck Cancer Squamous Cell Carcinoma, Breast Cancer (Locally Advanced or Metastatic)
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 1
150
Shanghai
2025-05-16
Not yet open
Zhongguang Luo, MD
Phase 2
15
Shanghai
2025-05-15
Recruiting
Ruijin Hospital
Phase 1
84
Shanghai
2025-05-15
Not yet open
Changhai Hospital
Phase 2
45
Shanghai
2025-05-15
Recruiting
Fudan University
Phase 1/2
68
Shanghai
2025-05-13
Recruiting
Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal
NCT07370337Squamous Cell Carcinoma of External Auditory Canal, Locally Advanced Tumor
DrugTislelizumab
Eye & ENT Hospital of Fudan University
Phase 2
50
Shanghai
2025-05-12
Recruiting
Shanghai Chest Hospital
Not applicable
15
Shanghai
2025-05-12
Recruiting
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06801236Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer)
Acerand Therapeutics (Hong Kong) Limited
Phase 1
88
Beijing, Hangzhou, Shanghai, Zhengzhou, Fuzhou
2025-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Guangzhou, Changsha, Shanghai, Kunming
2025-05-12
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1/2
166
Beijing, Xiamen, Guangzhou, Harbin, Changsha, Changchun, Shanghai
2025-05-12
Recruiting
Fudan University
Phase 1/2
139
Shanghai
2025-05-12
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
20
Shanghai
2025-05-11
Active, closed
Realistic in Generation of HEp-2 Cell Images Using Latent Diffusion Models: a Multi-center Visual Turing Test
NCT06542783Autoimmune / Connective Tissue Diseases, Anti-Nuclear Antibody, Visual Turing Tests, Artifical Intelligence
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
300
Shanghai
2025-05-10
Recruiting
Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology.
NCT06978348Ischemic Cerebrovascular Disease, Artificial Intelligence, Prediction Model
Shanghai Jiao Tong University School of Medicine
Observational
244,296
Shanghai
2025-05-10
Recruiting
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
300
Shanghai
2025-05-09
Recruiting
Fudan University
Observational
300
Shanghai
2025-05-09
Recruiting
Fudan University
Phase 2
130
Shanghai
2025-05-08
Recruiting
HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
NCT06769425Recurrent Ovarian Cancer, HER2-negative, Advanced Breast Cancer, TNBC
DrugsHS-10502·NHA)·HS-20089·Ris-Rez
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
157
Shanghai
2025-05-07
Recruiting
Genzyme, a Sanofi Company
Phase 4
13
Shanghai
2025-05-07
Not yet open
Shanghai Jiao Tong University School of Medicine
Not applicable
20,000
Shanghai
2025-05-06
Active, closed
A Randomized Controlled Trial of Robotic Support for Enhanced Later Life (RoSELL)
NCT07102017Loneliness, Well-Being, Psychological, Depression - Major Depressive Disorder
Shanghai Jiao Tong University School of Medicine
Not applicable
90
Shanghai
2025-05-06
Recruiting
Takeda
Phase 2
88
Beijing, Guangzhou, Changchun, Shanghai
2025-05-06
Not yet open
Xiaonan Huang
Not applicable
30
Shanghai
2025-05-05
Recruiting
Predicting High-Flow Nasal Oxygen Failure Within 72 Hours Using a Physiology-Informed Dual-Domain Model at 30 Minutes
NCT07366541Acute Respiratory Failure, Electrical Impedance Tomography (EIT), High-Flow Nasal Oxygen Therapy
Ruijin Hospital
Observational
115
Shanghai
2025-05-01
Recruiting
Bovine Reinforcement in Stomach, Colorectal and Lung Operation
NCT06968221Rectal Cancer Stage III, Lung Cancer Stage III
Shanghai Cingularbio Co. Ltd
Phase 3
172
Shanghai
2025-05-01
By invitation
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
44
Shanghai
2025-05-01
Not yet open
Fudan University
Phase 2
74
Shanghai
2025-05-01
Recruiting
Zhen Zhang
Not applicable
103
Shanghai
2025-05-01
Recruiting
Efficacy of Triple-daily 15mA tACS on Adolescent NSSI
NCT06919432Non-suicidal Self-injury (NSSI)
Shanghai Mental Health Center
Not applicable
66
Shanghai
2025-05-01
Recruiting
An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT06939569Inflammatory Bowel Disease (IBD), Metabolic Dysfunction Associated Fatty Liver Disease
Shanghai East Hospital
Observational
337
Shanghai
2025-05-01
Not yet open
Zhongguang Luo, MD
Phase 2
42
Shanghai
2025-05-01
Recruiting
Sleep Disorders and Tumor Immune Microenvironment
NCT06941948Impact of Sleep Disorders on Tumor Immune Microenvironment and Clinical Outcomes in Lung Cancer
Shanghai Zhongshan Hospital
Observational
400
Shanghai
2025-05-01
Recruiting
AstraZeneca
Phase 1
72
Beijing, Shanghai, Wuhan, Zhengzhou
2025-05-01
Not yet open
Active Surveillance for Limited GGNs
NCT06394037Lung Ground-glass Opacities, Active Surveillance
Fudan University
Observational
387
Shanghai
2025-05-01
Not yet open
Shanghai Zhongshan Hospital
Phase 2
53
Shanghai
2025-05-01
Recruiting
HiSCs in the Treatment of Rheumatoid Arthritis
NCT06947746Rheumatoid Arthritis (RA)
Shanghai Changzheng Hospital
Not applicable
15
Shanghai
2025-05-01
Not yet open
Ruijin Hospital
Not applicable
212
Luoyang, Jinan, Shanghai, Wenzhou
2025-05
Not yet open
Huashan Hospital
Observational
1,200
Shanghai
2025-05
Not yet open
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
NCT06980207Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations and Delusions Associated With Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia
DrugLY03017
Luye Pharma Group Ltd.
Phase 1
40
Shanghai
2025-05
Active, closed
Suzhou Junjing BioSciences Co., Ltd.
Phase 1/2
44
Shanghai
2025-04-30
Recruiting
Changhai Hospital
Not applicable
134
Shanghai
2025-04-30
Not yet open
Ruijin Hospital
Not applicable
60
Shanghai
2025-04-30
Recruiting
Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE）
NCT07004634Esophageal Cancer, Drainage/Methods, Postoperative Pain
Ruijin Hospital
Not applicable
75
Shanghai
2025-04-30
Recruiting
The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery
NCT06931743Thyroid Surgery, Electrical Stimulation, Thyroid Carcinoma
Xiaonan Huang
Not applicable
668
Shanghai
2025-04-30
Recruiting
High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps
NCT07463287MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai East Hospital
Observational
100
Shanghai
2025-04-30
Recruiting
Shanghai Mental Health Center
Not applicable
110
Shanghai
2025-04-30
Recruiting
Eikon Therapeutics
Phase 1/2
130
Chongqing, Jinan, Shanghai
2025-04-30
Recruiting
Hoffmann-La Roche
Phase 1
405
Guangzhou, Shanghai, Wuhan
2025-04-30
Recruiting
FGF19 Overexpression Combination Unified Study in HCC-19
NCT06978933HCC - Hepatocellular Carcinoma
DrugABSK-011
RenJi Hospital
Phase 2
42
Shanghai
2025-04-30
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Yinchuan, Jining, Xian, Beijing, Shanghai
2025-04-30
Recruiting
JHM BioPharma (Tonghua) Co. , Ltd.
Phase 3
669
Beijing, Chongqing, Guangzhou, Shijiazhuang, Changsha, Xuzhou, Shanghai, Xianyang
2025-04-30
Recruiting
Shanghai East Hospital
Phase 3
2,423
Suzhou, Shanghai
2025-04-30
Active, closed
Study for AZD4360 in Participants With Advanced Solid Tumours
NCT06921928Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
AstraZeneca
Phase 1/2
31
Beijing, Chengdu, Shanghai, Wuhan
2025-04-29
Recruiting
TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System
NCT06818084AORTIC VALVE DISEASES, Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR)
Ruijin Hospital
Phase 4
120
Shanghai
2025-04-29
Recruiting
Changhai Hospital
Phase 4
58
Shanghai
2025-04-28
Recruiting
Xiujuan Zang
Observational
1,890
Shanghai
2025-04-28
Not yet open
Fudan University
Phase 3
168
Shanghai
2025-04-28
Recruiting
Huashan Hospital
Observational
523
Shanghai
2025-04-27
Recruiting
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
154
Shanghai
2025-04-27
Recruiting
Shanghai Ruiwei Digital Technology Co. Ltd.
Not applicable
270
Shanghai
2025-04-25
Recruiting
Fudan University
Phase 2
60
Shanghai
2025-04-25
Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Phase 1/2
146
Beijing, Guangzhou, Nanjing, Shanghai
2025-04-25
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2/3
840
Shanghai
2025-04-25
Recruiting
Xijing Hospital
Observational
450
Xi'an, Chengdu, Beijing, Shanghai
2025-04-24
Active, closed
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase 2
150
Shanghai
2025-04-24
Recruiting
BioRay Pharmaceutical Co., Ltd.
Phase 1
166
Shanghai
2025-04-24
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
50
Shanghai
2025-04-24
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
84
Beijing, Shanghai
2025-04-24
By invitation
Xi Tan
Observational
50
Shanghai
2025-04-24
By invitation
Ruijin Hospital
Not applicable
100
Shanghai
2025-04-23
Recruiting
BioNTech SE
Phase 1/2
380
Bengbu, Changchun, Chengdu, Chongqing, Huizhou, Nanning, Shanghai, Xi'an
2025-04-23
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
60
Beijing, Shanghai
2025-04-23
Recruiting
Shanghai Henlius Biotech
Phase 2
167
Jinan, Shanghai
2025-04-22
Recruiting
Eye & ENT Hospital of Fudan University
Observational
105
Shanghai
2025-04-22
Recruiting
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase 1/2
50
Shanghai
2025-04-22
By invitation
Breast Cancer PET/CT Imaging With 68Ga-pAKTi
NCT06943313Breast Cancers, PIK3CA Mutation-Related Tumors, PI3K Pathway Activated Tumors, PET / CT
Fudan University
Observational
20
Shanghai
2025-04-21
Recruiting
Fudan University
Phase 2
60
Shanghai
2025-04-21
Recruiting
Fudan University
Not applicable
140
Shanghai
2025-04-21
Recruiting
Fudan University
Phase 2
10
Shanghai
2025-04-21
Recruiting
RGL-305+ Lymphoma + Exploratory Clinical Study
NCT07006012Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Fudan University
Not applicable
12
Shanghai
2025-04-21
Recruiting
Shanghai 6th People's Hospital
Observational
400
Shanghai
2025-04-20
Recruiting
ChinaNorm
Not applicable
76
Shanghai
2025-04-20
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 1
21
Shanghai
2025-04-20
Not yet open
Shanghai Zhongshan Hospital
Observational
66
Shanghai
2025-04-20
Active, closed
Gamified Digital Balance Assessment
NCT07088848Disease Prevention
Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2025-04-20
Active, closed
Xu Liu
Not applicable
78
Shanghai
2025-04-20
Recruiting
Cryoablation vs Thoracoscopic Surgery for GGN
NCT06848881Ground-Glass Opacity
Shanghai Chest Hospital
Not applicable
160
Shanghai
2025-04-20
Active, closed
A ReaL World Study of DS-8201
NCT06945224Breast Cancer Metastatic, Treatment Efficacy
Fudan University
Observational
300
Shanghai
2025-04-19
Recruiting
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
NCT06974812Unresectable Locally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
250
Fuzhou, Changsha, Shanghai
2025-04-18
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
98
Shanghai
2025-04-17
Recruiting
Shanghai Henlius Biotech
Phase 2
50
Shanghai
2025-04-16
Recruiting
Shanghai Zhongshan Hospital
Phase 2
150
Xiamen, Shanghai, Wenzhou
2025-04-16
By invitation
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2025-04-16
Recruiting
Electrical Impedance Tomography-Based Prognostic Model for ARDS
NCT06967207Acute Respiratory Distress Syndrome (ARDS), Ventilator-induced Lung Injury
XiaoJing Zou,MD
Observational
625
Guangzhou, Wuhan, Shanghai
2025-04-15
Recruiting
Shanghai Changzheng Hospital
Phase 4
50
Shanghai
2025-04-15
Active, closed
Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06914687Gastric Adenocarcinoma, Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Peritoneal Metastasis
DrugsTeysuno·Tislelizumab·Docetaxel·Oxaliplatin
Fudan University
Phase 2
30
Shanghai
2025-04-15
Recruiting
Shanghai Changzheng Hospital
Not applicable
201
Shanghai
2025-04-15
Recruiting
Shanghai Changzheng Hospital
Phase 4
96
Shanghai
2025-04-15
Not yet open
MicroPort NeuroTech Co., Ltd.
Phase 3
279
Shanghai
2025-04-15
Not yet open
Jin Xu
Phase 2
46
Shanghai
2025-04-15
Recruiting
AbbVie
Phase 1
232
Guangzhou, Shanghai
2025-04-14
Recruiting
Changhai Hospital
Observational
5,000
Shanghai
2025-04-13
Recruiting
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
NCT07089186Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI), Complicated Urinary Tract Infection (cUTI)
DrugMeropenem and Pralurbactam
Qilu Pharmaceutical Co., Ltd.
Phase 3
80
Shanghai
2025-04-12
Recruiting
International Peace Maternity and Child Health Hospital
Phase 2
20
Shanghai
2025-04-12
Recruiting
Ruijin Hospital
Observational
100
Shanghai
2025-04-12
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2
374
Shanghai
2025-04-11
Recruiting
Shanghai JMT-Bio Inc.
Phase 1/2
436
Shanghai
2025-04-11
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
245
Guiyang, Nanjing, Shanghai
2025-04-11
Recruiting
Shanghai University of Traditional Chinese Medicine
Not applicable
20
Shanghai
2025-04-10
Recruiting
Universal CAR-T Cell Therapy for MM
NCT07248176Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Bioray Laboratories
Not applicable
6
Shanghai
2025-04-10
Recruiting
Shanghai Changzheng Hospital
Phase 4
64
Changhua, Shanghai
2025-04-10
Recruiting
Shanghai Changzheng Hospital
Phase 2
60
Shanghai
2025-04-10
Not yet open
Hansoh BioMedical R&D Company
Phase 2
305
Shanghai
2025-04-09
Recruiting
Epygenix
Phase 3
260
Changsha, Shanghai, Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Guiyang
2025-04-09
Active, closed
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Phase 3
439
Shanghai
2025-04-08
Recruiting
Neoadjuvant SNF Precision Therapy Phase III
NCT06913777Neoadjuvant Therapy
DrugFamitinib
Fudan University
Phase 3
404
Shanghai
2025-04-08
Recruiting
Fudan University
Observational
1,500
Shanghai
2025-04-07
Recruiting
Shanghai 10th People's Hospital
Not applicable
686
Shanghai
2025-04-07
Recruiting
CAR-NK Cells (CL-NK-001) in Pancreatic Cancer
NCT06816823Pancreatic Cancer
Changhai Hospital
Phase 1
30
Shanghai
2025-04-07
Recruiting
Children's Hospital of Fudan University
Observational
300
Shanghai
2025-04-07
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Observational
1,500
Guiyang, Changchun, Jinan, Shanghai, Jiaxing
2025-04-06
Not yet open
RenJi Hospital
Phase 2
30
Shanghai
2025-04-05
Recruiting
Vigonvita Life Sciences
Phase 2
400
Shanghai
2025-04-03
Active, closed
Shanghai Zhongshan Hospital
Early Phase 1
29
Shanghai
2025-04-03
Recruiting
Shanghai Zhongshan Hospital
Phase 2
90
Changsha, Shanghai
2025-04-03
Recruiting
Inmunotek S.L.
Phase 3
736
Beijing, Guangzhou, Zhongshan, Xiangya, Changzhou, Qingdao, Shanghai, Tongji
2025-04-02
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
NCT06346600Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics
Observational
83
Hefei, Hangzhou, Wenzhou, Beijing, Shanghai
2025-04-02
Recruiting
Shanghai Clinical Cohort of Hyperglycemia in Pregnancy
NCT07161947Hyperglycemia in Pregnant Diabetic Patients, Gestatiaonl Diabetes Mellitus
Shanghai General Hospital, China
Observational
4,000
Shanghai
2025-04-01
Recruiting
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
NCT07353463Parkinson's Disease (PD), Multiple System Atrophy
Ruijin Hospital
Observational
700
Shanghai
2025-04-01
Recruiting
A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis
NCT07314489Chronic Pancreatitis Pancreatic Exocrine Insufficiency Blood Glucose
Shanghai Changzheng Hospital
Early Phase 1
80
Shanghai
2025-04-01
Active, closed
Acute Myocardial Infarction Clinical Cohort
NCT07522164Acute Myocardial Infarction
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2025-04-01
Recruiting
Fudan University
Phase 2
100
Shanghai
2025-04-01
Recruiting
Pfizer
Phase 3
674
Beijing, Chongqing, Guangzhou, Changsha, Nanchang, Shanghai, Chengdu, Kunming
2025-04-01
Recruiting
RenJi Hospital
Not applicable
127
Shanghai
2025-04-01
Not yet open
Huashan Hospital
Phase 4
360
Shanghai
2025-04-01
Recruiting
Ruijin Hospital
Phase 2
152
Shanghai
2025-04-01
Recruiting
A National Multicenter Survey on Small Vulnerable Newborns
NCT07143825Preterm, Small Gestational Age (SGA)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
2,000
Shanghai
2025-04-01
Not yet open
Ruijin Hospital
Observational
15
Shanghai
2025-04-01
Recruiting
Child-Parent Familial Hypercholesterolemia Screening
NCT04529967Familial Hypercholesterolemia
Children's Hospital of Fudan University
Observational
15,000
Hefei, Qidong, Shanghai, Taiyuan, Chongqing, Ürümqi
2025-04-01
Recruiting
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
NCT06925464T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital
Phase 1/2
36
Beijing, Zhanjiang, Shanghai
2025-04-01
By invitation
Nanjing Medical University
Not applicable
200
Beijing, Guangzhou, Shanghai, Chengdu
2025-04-01
Active, closed
Shanghai 10th People's Hospital
Observational
90
Shanghai
2025-04-01
Not yet open
Shanghai IxCell Biotechnology Co., LTD
Phase 1
18
Shanghai
2025-04-01
Not yet open
Ruijin Hospital
Early Phase 1
10
Shanghai
2025-04-01
Recruiting
Lin Kong, MD
Phase 3
470
Shanghai
2025-04-01
Recruiting
Shanghai Chest Hospital
Not applicable
162
Shenyang, Shanghai, Huizhou
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Wuhan
2025-04-01
Recruiting
Changhai Hospital
Not applicable
308
Shanghai
2025-04-01
Active, closed
Xinghua Cheng
Observational
300
Shanghai
2025-04-01
Recruiting
Eye & ENT Hospital of Fudan University
Early Phase 1
10
Shanghai
2025-04-01
Not yet open
Fudan University
Phase 2
120
Shanghai
2025-04-01
Not yet open
Linno Pharmaceuticals, Inc.
Phase 1
56
Shanghai
2025-04
Not yet open
Shanghai Changzheng Hospital
Not applicable
60
Shanghai
2025-04
Not yet open
Shanghai Henlius Biotech
Phase 3
386
Shanghai
2025-04
Not yet open
Shanghai Chest Hospital
Not applicable
119
Shanghai
2025-04
Recruiting
HANDLE-a Real World Study on Satralizumab in NMOSD
NCT06829524Neuromyelitis Optica Spectrum Disorders (NMOSD)
DrugSatralizumab
Huashan Hospital
Observational
100
Shanghai
2025-03-31
Recruiting
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1
200
Shanghai
2025-03-31
Not yet open
Shanghai Chest Hospital
Phase 2
30
Shanghai
2025-03-31
Not yet open
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037Gastric Adenocarcinoma, GEJ Adenocarcinoma, First-line Therapy, Maintenance Therapy
Ruijin Hospital
Phase 2
55
Shanghai
2025-03-31
Not yet open
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1/2
150
Shanghai
2025-03-31
Recruiting
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 3
380
Shanghai
2025-03-30
Active, closed
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
145
Shanghai
2025-03-28
Recruiting
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1/2
260
Shanghai
2025-03-28
Recruiting
AstraZeneca
Phase 1/2
304
Chengdu, Guangzhou, Harbin, Shanghai
2025-03-27
Recruiting
Shanghai Zhongshan Hospital
Phase 4
1,670
Shanghai
2025-03-27
Active, closed
Suzhou Genhouse Bio Co., Ltd.
Phase 1
126
Beijing, Shanghai
2025-03-27
Active, closed
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
NCT06895811Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Shanghai Changzheng Hospital
Phase 1
3
Shanghai
2025-03-27
Recruiting
Shanghai 6th People's Hospital
Not applicable
100
Shanghai
2025-03-26
Recruiting
PDO Based Drug Sensitive Test in R/M HNSCC
NCT06686342Head and Neck Squamous Cell Carcinoma, Patient Derived Organoid, Drug Sensitive Test in Vitro
Huashan Hospital
Observational
100
Shanghai
2025-03-26
Recruiting
PDO Based Drug Sensitive Test in R/M SGC
NCT06686979Salivary Gland Cancers, Patient Derived Organoid, Drug Sensitive Test in Vitro
Huashan Hospital
Observational
40
Shanghai
2025-03-26
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
515
Shanghai
2025-03-25
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 3
194
Hangzhou, Harbin, Hefei, Jinhua, Nanchang, Nantong, Shanghai, Ürümqi
2025-03-24
Recruiting
Chongqing Precision Biotech Co., Ltd
Phase 1
60
Shanghai
2025-03-24
Recruiting
Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients
NCT07741279Anemia of Chronic Kidney Disease, CKD, Non-dialysis Chronic Kidney Disease
DrugEnarodustat
Huashan Hospital
Observational
90
Shanghai
2025-03-23
Recruiting
Ruijin Hospital
Phase 1/2
20
Qionghai, Shanghai
2025-03-23
Active, closed
Shanghai Chest Hospital
Not applicable
156
Shanghai
2025-03-23
Recruiting
Children's Hospital of Fudan University
Phase 3
44
Shanghai
2025-03-22
Active, closed
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Phase 1/2
12
Shanghai
2025-03-21
Active, closed
Shanghai Mental Health Center
Not applicable
40
Shanghai
2025-03-20
Recruiting
Fudan University
Phase 2
30
Shanghai
2025-03-20
Active, closed
Jian Li
Phase 1
30
Beijing, Hohhot, Shanghai
2025-03-20
Not yet open
Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer
NCT05562297Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB, Pancreatic Cancer Stage III
DrugsAbraxane·Sintilimab·Nab-paclitaxel·Gemcitabine
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2025-03-20
Recruiting
Fudan University
Phase 2
164
Shanghai
2025-03-18
Recruiting
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
NCT06803680Advanced Solid Tumor, Metastatic Solid Tumor
BeOne Medicines
Phase 1
90
Beijing, Nanchang, Shanghai, Taiyuan
2025-03-18
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Phase 2/3
296
Shanghai
2025-03-18
By invitation
Ruijin Hospital
Not applicable
180
Shanghai
2025-03-18
Recruiting
Fudan University
Phase 2
92
Shanghai
2025-03-18
Not yet open
Changhai Hospital
Not applicable
438
Shanghai
2025-03-17
Active, closed
Guangzhou Medical University
Phase 1/2
39
Beijing, Huizhou, Shanghai
2025-03-17
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
54
Shanghai
2025-03-17
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
35
Shanghai
2025-03-15
Active, closed
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
388
Shanghai
2025-03-15
Recruiting
Ruijin Hospital
Not applicable
10
Shanghai
2025-03-15
Active, closed
Hoffmann-La Roche
Phase 4
274
Beijing, Chengdu, Guangzhou, Shanghai, Wuhan
2025-03-14
Recruiting
RenJi Hospital
Observational
114
Beijing, Guangdong, Guizhou, Jiangsu, Shanghai, Sichuan, Tianjin, Zhejiang
2025-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
60
Beijing, Chongqing, Guangzhou, Nanjing, Changchun, Hangzhou, Shanghai
2025-03-13
Recruiting
The Dental Hospital of Zhejiang University School of Medicine
Not applicable
40
Wuhan, Hangzhou, Shanghai
2025-03-12
Recruiting
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.
Phase 2
90
Shanghai
2025-03-12
Active, closed
Ruijin Hospital
Phase 1
9
Guangzhou, Shanghai, Chengdu
2025-03-12
Recruiting
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
By invitation
Changhai Hospital
Observational
600
Shanghai
2025-03-11
Recruiting
Universal CAR-T Cell Therapy for NHL
NCT07248163Non-hodgkin Lymphoma,B Cell
DrugBRL-301
Bioray Laboratories
Not applicable
6
Shanghai
2025-03-11
Not yet open
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
20
Shanghai
2025-03-10
By invitation
Guangzhou Jiayin Biotech Ltd
Early Phase 1
4
Shanghai
2025-03-10
Recruiting
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Early Phase 1
18
Nanyang, Shanghai
2025-03-10
Recruiting
Fudan University
Phase 2
221
Shanghai
2025-03-10
Recruiting
Translation and Validation of Chinese COMPAT-SF
NCT06917716Chronic Pancreatitis
Changhai Hospital
Observational
356
Shanghai
2025-03-10
Active, closed
Shanghai Changzheng Hospital
Early Phase 1
7
Shanghai
2025-03-10
Recruiting
Fudan University
Phase 2
44
Shanghai
2025-03-09
Not yet open
Zhiguo Luo, MD, PhD
Phase 2
50
Shanghai
2025-03-08
Active, closed
ChinaNorm
Not applicable
66
Shanghai
2025-03-08
Active, closed
Guangzhou Medical University
Phase 1/2
39
Huizhou, Beijing, Shanghai
2025-03-07
Recruiting
Hongmei Wang
Phase 1/2
40
Shanghai
2025-03-07
Recruiting
Fudan University
Phase 3
182
Shanghai
2025-03-07
Active, closed
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores, AMR
DrugALXN2030
Alexion Pharmaceuticals, Inc.
Phase 2
47
Changsha, Guangzhou, Nanning, Shanghai, Wuhan, Xi'an
2025-03-07
Recruiting
Huashan Hospital
Not applicable
20
Shanghai
2025-03-06
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 1
180
Shanghai
2025-03-06
Recruiting
A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors
NCT06716138Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration
Avistone Biotechnology Co., Ltd.
Phase 1
96
Fuzhou, Guangzhou, Shanghai, Chengdu
2025-03-06
Active, closed
Xu Liu
Not applicable
212
Shanghai
2025-03-05
Recruiting
Peking University
Phase 1
78
Beijing, Shanghai
2025-03-04
Recruiting
Allist Pharmaceuticals, Inc.
Phase 1
120
Shanghai
2025-03-04
Not yet open
Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999Atrial Fibrillation, Atrial Fibrillation, Paroxysmal or Persistent, Deep Sedations, Conscious Sedation
The First Affiliated Hospital of Dalian Medical University
Not applicable
1,334
Hefei, Guangzhou, Nanjing, Suzhou, Nanchang, Dalian, Qingdao, Shanghai
2025-03-03
By invitation
A Study on Multimodal Prognostic Scoring of Advanced PDAC.
NCT07373691Pancreatic Ductal Adenocarcinoma (PDAC)
RenJi Hospital
Observational
100
Shanghai
2025-03-02
Recruiting
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1
94
Shanghai
2025-03-02
Recruiting
Shanghai 6th People's Hospital
Observational
100
Shanghai
2025-03-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
450
Hangzhou, Shanghai
2025-03-01
Active, closed
Shanghai UniXell Biotechnology Co., Ltd
Phase 1
12
Shanghai
2025-03-01
Not yet open
Ruijin Hospital
Observational
50
Shanghai
2025-03-01
Recruiting
Shanghai Cancer Hospital, China
Phase 2
97
Shanghai
2025-03-01
Recruiting
Shanghai Zhongshan Hospital
Observational
1,450
Guangzhou, Nanchang, Shenyang, Jinan, Shanghai
2025-03-01
Active, closed
Ruijin Hospital
Not applicable
388
Shanghai
2025-03-01
Recruiting
Huashan Hospital
Phase 2
66
Shanghai
2025-03-01
Not yet open
Children's Hospital of Fudan University
Phase 3
138
Shanghai
2025-03-01
Recruiting
Perioperative Immunotherapy for Resectable Limited-Stage SCLC
NCT07109401Perioperative Immunotherapy, Limited Stage Lung Small Cell Carcinoma, Resectable Small Cell Lung Cancer
DrugTislelizumab
Fudan University
Phase 2
37
Shanghai
2025-03-01
Not yet open
Fudan University
Observational
2,700
Shanghai
2025-03-01
Recruiting
Investigation of Tetralogy of Fallot in Neonates
NCT06822400Tetralogy of Fallot (TOF), Pulmonary Stenosis, Ventricular Septal Defects (VSD), Double Outlet Right Ventricle
Beijing Anzhen Hospital
Not applicable
160
Beijing, Chengdu, Shanghai, Shenzhen, Suzhou
2025-03-01
Recruiting
Baohui Han
Observational
508
Shanghai
2025-03-01
Not yet open
Shanghai Changzheng Hospital
Phase 2/3
60
Shanghai
2025-03-01
Recruiting
Shanghai Zhongshan Hospital
Observational
30
Shanghai
2025-03-01
Recruiting
Shanghai Zhongshan Hospital
Observational
1,000
Shanghai
2025-03-01
Recruiting
Fudan University
Phase 2
208
Fuzhou, Xiamen, Lanzhou, Zhengzhou, Huaian, Jinan, Taian, Shanghai
2025-03-01
Recruiting
Ruijin Hospital
Not applicable
246
Shanghai
2025-03-01
Recruiting
Research on Wireless Brain Implant System for General Control of External Devices
NCT06829212Complete or Incomplete Paraplegia/quadriplegia, Spinal Cord Injury, Brainstem Stroke, Amyotrophic Lateral Sclerosis
Shanghai StairMed Technology Co., Ltd.
Not applicable
4
Shanghai
2025-03
Not yet open
Huashan Hospital
Not applicable
632
Shanghai
2025-03
Recruiting
KPD Consolidation After ASCT in NDMM Patients
NCT06879379Multiple Myeloma, Newly Diagnosed
Peking University People's Hospital
Phase 2/3
202
Beijing, Shanghai
2025-03
By invitation
Guangzhou Jiayin Biotech Ltd
Observational
18
Shanghai
2025-03
Recruiting
Bangdong Gong
Phase 1/2
6
Shanghai
2025-02-28
Recruiting
Fudan University
Phase 2
119
Shanghai
2025-02-28
Recruiting
Wuxi Cellular Biopharmaceutical Group Ltd.
Phase 3
520
Shanghai
2025-02-28
Not yet open
Real-World Study of Myopia Prevention and Control in Children
NCT06849895Myopia, Refractive Errors, Children, Cohort
Shanghai Eye Disease Prevention and Treatment Center
Observational
15,000
Shanghai
2025-02-28
Not yet open
AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT06860789Chemotherapy-induced Peripheral Neuropathy (CIPN)
Akeso
Phase 1
85
Guangzhou, Shanghai
2025-02-28
Recruiting
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
NCT06856200Advanced HR - Positive, HER2 - Negative Breast Cancer, Resistant to (Neo)Adjuvant Endocrine Therapy
DrugsSirolimus·Palbociclib·Fulvestrant
Fudan University
Not applicable
36
Shanghai
2025-02-28
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
327
Beijing, Fuzhou, Nanjing, Shanghai, Chengdu, Hangzhou
2025-02-27
Recruiting
Fudan University
Phase 2
36
Shanghai
2025-02-26
Recruiting
Pathogen Detection in Infectious Uveitis
NCT04521673Infectious Panuveitis, Infectious Iridocyclitis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
100
Shanghai
2025-02-26
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
54
Harbin, Shanghai
2025-02-26
Recruiting
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
NCT06792552Advanced Solid Tumors, Platinum Resistant Ovarian Cancer, Fallopian Tube Cancer, Renal Cell Carcinoma (RCC)
NextCure, Inc.
Phase 1
738
Beijing, Shenyang, Shijiazhuang, Guangzhou, Changsha, Jinan, Jining, Shanghai
2025-02-26
Active, closed
Medtronic Cardiac Rhythm and Heart Failure
Observational
50
Wenzhou, Shanghai
2025-02-26
Recruiting
IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)
NCT06849986Soft Tissue Sarcomas, Angiosarcoma, Fibrosarcoma, Leiomyosarcoma
DrugsLiposomal doxorubicin·Ifosfamide·Tislelizumab
Fudan University
Phase 2
45
Shanghai
2025-02-25
Active, closed
Singlera Genomics Inc.
Observational
900
Shanghai
2025-02-25
Recruiting
Ruijin Hospital
Phase 2
40
Shanghai
2025-02-25
Not yet open
Shanghai Chest Hospital
Not applicable
60
Shanghai
2025-02-24
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
720
Shanghai
2025-02-24
Not yet open
Shanghai Jiao Tong University School of Medicine
Not applicable
400
Shanghai
2025-02-24
Recruiting
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy
NCT06878378Colonoscopy, Colonoscopy: Bowel Preparation
Changhai Hospital
Observational
10,000
Shanghai
2025-02-21
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
246
Guangzhou, Guiyang, Wuhan, Yichang, Changsha, Yongzhou, Shanghai
2025-02-21
Recruiting
A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients
NCT07641686Hair Transplantation, Seborrheic Dermatitis, Scalp Care
ChinaNorm
Not applicable
120
Shanghai
2025-02-21
Recruiting
Shanghai Zhongshan Hospital
Not applicable
76
Shanghai
2025-02-21
Recruiting
Shanghai Chest Hospital
Phase 2
124
Shanghai
2025-02-20
Recruiting
Coronary Aspiration Catheter Clinical Trial
NCT06951724ST-segment Elevation Myocardial Infarction (STEMI)
BrosMed Medical Co., Ltd
Not applicable
144
Shanghai
2025-02-20
Recruiting
Peking Union Medical College Hospital
Not applicable
524
Lanzhou, Guangzhou, Cangzhou, Shijiazhuang, Changsha, Changchun, Shanghai, Xianyang
2025-02-20
Recruiting
Shanghai Zhongshan Hospital
Phase 2/3
398
Harbin, Shanghai
2025-02-20
Recruiting
IBSA Farmaceutici Italia Srl
Not applicable
500
Beijing, Changde, Chengdu, Shanghai, Xi'an
2025-02-19
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
400
Shanghai
2025-02-18
Recruiting
The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
NCT07015580Oral Microbiota, Pancreatitis, Pancreatic Cancer
Ruijin Hospital
Observational
360
Shanghai
2025-02-18
Recruiting
JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer
NCT06846437Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants
DrugsJSKN003·Trastuzumab emtansine
Shanghai JMT-Bio Inc.
Phase 3
228
Shanghai
2025-02-18
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
160
Shanghai
2025-02-18
Recruiting
Effect of Low Valine Diet on Body Weight and Metabolic Parameters
NCT06883578Overweight/obesity, Metabolic Associated Fatty Liver Disease, Metabolic Diseases
Shanghai Zhongshan Hospital
Not applicable
48
Shanghai
2025-02-18
Active, closed
Gilead Sciences
Phase 2
39
Chengdu, Hangzhou, Nanning, Shanghai, Wuhan
2025-02-18
Recruiting
Fudan University
Phase 2
20
Shanghai
2025-02-17
Not yet open
Fudan University
Observational
300
Shanghai
2025-02-15
Recruiting
Fudan University
Phase 2
27
Shanghai
2025-02-15
Not yet open
Fudan University
Phase 2
50
Shanghai
2025-02-15
Not yet open
Chongbo Zhao
Phase 1
18
Shanghai
2025-02-15
Recruiting
Bayer
Phase 2
111
Beijing, Changsha, Shanghai, Hangzhou
2025-02-13
Recruiting
Fudan University
Phase 3
502
Shanghai
2025-02-12
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
22
Shanghai
2025-02-12
Recruiting
Reverse HER2-negative Immune Resistant Breast Cancer
NCT06731140HER2 Negative Breast Cancer
Fudan University
Phase 2
10
Shanghai
2025-02-12
Recruiting
Ruijin Hospital
Not applicable
80
Shanghai
2025-02-10
Recruiting
A Study of GC203 TIL in PDCA (RJ)
NCT06828328Pancreatic Cancer, Pancratic Ductal Adenocarcinoma, Treatment Side Effects, Tumor Infiltrating Lymphocytes
DrugEngineering Tumor Infiltrating Lymphocytes
Shanghai Juncell Therapeutics
Early Phase 1
10
Shanghai
2025-02-10
Not yet open
Fudan University
Phase 2
80
Shanghai
2025-02-10
Not yet open
Clinical Classification of MAFLD Based Liver Biopsy
NCT06795646Metabolic Dysfunction Associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital
Observational
2,000
Beijing, Hangzhou, Shanghai, Tianjin
2025-02-08
Recruiting
RenJi Hospital
Not applicable
20
Shanghai
2025-02-08
Active, closed
Genmab
Phase 3
584
Guangzhou, Xi'an, Changchun, Hanzhou, Shanghai, Tianjin, Zhengzhou
2025-02-07
Recruiting
RTMS for CHR Based on Personalized Targets Using Magnetoencephalography
NCT06802952Clinical High-risk Syndrome of Psychosis
Shanghai Mental Health Center
Not applicable
26
Shanghai
2025-02-07
Recruiting
Fudan University
Phase 2
34
Shanghai
2025-02-07
Recruiting
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
NCT06758700Extensive-stage Small Cell Lung Cancer (ES-SCLC), Thoracic Neoplasms, Lung Neoplasms, Lung Diseases
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
15
Shanghai
2025-02-07
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
42
Shanghai
2025-02-06
Recruiting
Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG
NCT06796725Migraine Disorders, Brain, rTMS Stimulation
Ruijin Hospital
Not applicable
60
Shanghai
2025-02-06
Recruiting
LEO Pharma
Phase 3
90
Beijing, Changchun, Changsha, Chengdu, Hangzhou, Jinan, Shanghai, Shenzhen
2025-02-05
Not yet open
Shanghai Zhongshan Hospital
Not applicable
42
Shanghai
2025-02-05
Recruiting
Shanghai Mental Health Center
Not applicable
36
Shanghai
2025-02-05
Recruiting
BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
NCT06793332Triple-Negative Breast Cancer (TNBC), Brain Metastases
DrugsTROP2 ADC·Ivonescimab
Fudan University
Phase 2
39
Shanghai
2025-02-05
Recruiting
A Real World Study of Sacituzumab Govitecan
NCT06966141Breast Cancer Metastatic, Treatment Outcome
Fudan University
Observational
100
Shanghai
2025-02-05
Recruiting
Shanghai Yizhong Pharmaceutical Co., Ltd.
Phase 3
416
Nanjing, Shanghai
2025-02-05
Recruiting
BeOne Medicines
Phase 1
120
Guangzhou, Zhengzhou, Shanghai, Tianjin, Hangzhou
2025-02-04
Recruiting
RCT of EFTR Versus STER for GIST Treatment
NCT07411118Small Size Gastrointestinal Stromal Tumors, GIST
Chinese University of Hong Kong
Not applicable
136
Shanghai
2025-02-01
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2025-02-01
Not yet open
Ruijin Hospital
Phase 2
47
Shanghai
2025-02-01
Recruiting
Yufan Wang
Observational
2,920
Lanzhou, Shanghai, Shenyang
2025-02-01
Recruiting
Ruijin Hospital
Phase 2
28
Shanghai
2025-02-01
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
NCT06798077Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
China-Japan Friendship Hospital
Observational
2,000
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Shenyang, Xi'an, Shanghai
2025-02-01
Recruiting
Ruijin Hospital
Observational
30
Shanghai
2025-02-01
Recruiting
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
NCT06964568Esophageal Carcinoma, Radiotherapy, Immunotherapy
Fudan University
Phase 3
452
Shanghai
2025-02-01
Active, closed
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
40
Shanghai
2025-02-01
Rows per page Showing 1501–2000 of 3879
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=4

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,879 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,418 of the 3,879 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 756 have not yet opened recruitment, 598 are active but closed to new participants, and 107 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.